Seizert Capital Partners LLC Has $10.63 Million Stake in CVS Health Corporation $CVS

Seizert Capital Partners LLC reduced its position in shares of CVS Health Corporation (NYSE:CVS) by 73.6% in the 2nd quarter, Holdings Channel reports. The institutional investor owned 154,160 shares of the pharmacy operator’s stock after selling 429,981 shares during the quarter. Seizert Capital Partners LLC’s holdings in CVS Health were worth $10,634,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. FineMark National Bank & Trust boosted its position in CVS Health by 1.7% during the 2nd quarter. FineMark National Bank & Trust now owns 9,576 shares of the pharmacy operator’s stock worth $661,000 after acquiring an additional 157 shares during the last quarter. Hazlett Burt & Watson Inc. lifted its position in shares of CVS Health by 10.9% in the second quarter. Hazlett Burt & Watson Inc. now owns 1,682 shares of the pharmacy operator’s stock worth $117,000 after purchasing an additional 165 shares in the last quarter. Williams Financial LLC boosted its holdings in CVS Health by 2.5% during the second quarter. Williams Financial LLC now owns 6,923 shares of the pharmacy operator’s stock worth $478,000 after purchasing an additional 167 shares during the last quarter. Hemington Wealth Management grew its position in CVS Health by 33.7% in the first quarter. Hemington Wealth Management now owns 682 shares of the pharmacy operator’s stock valued at $46,000 after purchasing an additional 172 shares in the last quarter. Finally, GW&K Investment Management LLC increased its stake in CVS Health by 39.4% in the 1st quarter. GW&K Investment Management LLC now owns 637 shares of the pharmacy operator’s stock valued at $43,000 after buying an additional 180 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Ratings Changes

CVS has been the subject of a number of recent research reports. Zacks Research downgraded shares of CVS Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 8th. Morgan Stanley upped their target price on CVS Health from $82.00 to $89.00 and gave the stock an “overweight” rating in a report on Tuesday, October 14th. Leerink Partners raised their price target on CVS Health from $86.00 to $95.00 and gave the company an “outperform” rating in a research note on Thursday, October 16th. Robert W. Baird raised CVS Health from a “neutral” rating to an “outperform” rating and boosted their price target for the stock from $71.00 to $82.00 in a research report on Thursday, August 14th. Finally, Wall Street Zen downgraded CVS Health from a “buy” rating to a “hold” rating in a report on Saturday, November 1st. Two equities research analysts have rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $89.41.

CVS Health Price Performance

NYSE:CVS opened at $77.93 on Wednesday. CVS Health Corporation has a 12-month low of $43.56 and a 12-month high of $85.15. The firm has a market capitalization of $98.93 billion, a price-to-earnings ratio of 205.08, a P/E/G ratio of 0.87 and a beta of 0.60. The stock’s 50 day moving average price is $77.98 and its two-hundred day moving average price is $70.09. The company has a quick ratio of 0.62, a current ratio of 0.83 and a debt-to-equity ratio of 0.83.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The business had revenue of $102.87 billion for the quarter, compared to analyst estimates of $98.85 billion. During the same period in the previous year, the firm earned $1.09 EPS. The firm’s revenue was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd were given a $0.665 dividend. The ex-dividend date of this dividend was Thursday, October 23rd. This represents a $2.66 annualized dividend and a dividend yield of 3.4%. CVS Health’s dividend payout ratio is presently 700.00%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.